ClinicalTrials.Veeva

Menu

EMPOWERing Patients With Chronic Diseases Through Smartphone App, Health Coaching and Shared Decision Making

S

Singapore Health Services (SingHealth)

Status

Active, not recruiting

Conditions

Hypertension
Diabetes Mellitus, Type 2

Treatments

Behavioral: Nudge, health coaching and shared decision-making

Study type

Interventional

Funder types

Other

Identifiers

NCT05486390
202203-00046

Details and patient eligibility

About

Chronic diseases are the leading cause of deaths in Singapore. The rising prevalence in chronic diseases with age and Singapore's rapidly aging population calls for new models of care to effectively prevent the onset and delay the progression of these diseases. Advancement in medical technology has offered new innovations that aid healthcare systems in coping with the rapid rising in healthcare needs. These include mobile applications, wearable technologies and machine learning-derived personalized behaviorial interventions. The overall goal of the project is to improve health outcomes in chronic disease patients through delivering targeted nudges via mobile application and wearable to sustain behavioral change. Our overall objective is to design, develop, and evaluate an adaptive intervention platform on wearable devices and shared decision-making during consultations for patients with diabetes and hypertension. Our aim for this study is to assess the clinical effectiveness of real-time personalized educational and behavioural interventions delivered through wearable (Fitbit) and an integrative mobile application in improving patient glycaemic control measured using HbA1c over 9 months. Secondary outcomes will include change in systolic blood pressure, quality of life (QoL), patient activation, medication adherence, physical activity level, diet, direct healthcare cost and indirect healthcare cost over 9 months. We will conduct a randomized controlled trial among patients with comorbid diabetes and hypertension. This proposal aims to develop sustainable and cost-effective behavioural change among patients with comorbid diabetes and hypertension through patient empowerment and targeted chronic disease care.

Enrollment

320 patients

Sex

All

Ages

21 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 21 years old and above
  2. Have been diagnosed with diabetes at time of recruitment
  3. Most recent glycated haemoglobin (HbA1c) ≥ 7.0%
  4. Systolic blood pressure≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg on two or more prior visits, physician-diagnosed hypertension, or on antihypertensive medication
  5. Physically able to exercise
  6. Literate in English
  7. Agreeable to be monitored by EMPOWER and/or Fitbit apps
  8. Able to conform to monitoring schedule

Exclusion criteria

  1. On bolus insulin treatment
  2. Require assistance with basic activities of daily living (BADL)
  3. Have planned major operation or surgical procedure within next 9 months
  4. Cognitively impaired (scored ≥ 6 on the Abbreviated Mental Test)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

320 participants in 2 patient groups

Intervention
Experimental group
Treatment:
Behavioral: Nudge, health coaching and shared decision-making
Control
No Intervention group

Trial contacts and locations

3

Loading...

Central trial contact

Lian Leng Low

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems